Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL15053276 | 0.98 | LMNA (0.34) | LMNA | |
| Bromide SCHEMBL15053213 | 0.98 | LMNA (0.34) | LMNA | |
| Bromide SCHEMBL15053511 | 0.98 | LMNA (0.34) | LMNA | |
| SCHEMBL4265229 | 0.98 | LMNA (0.32) | LMNA | |
| Hydrochloric Acid SCHEMBL365179 | 0.96 | LMNA (0.31) | LMNA | |
| Iodide SCHEMBL15008703 | 0.96 | LMNA (0.31) | LMNA | |
| SCHEMBL367893 | 0.96 | LMNA (0.35) | LMNA | |
| Hydrochloric Acid SCHEMBL2293581 | 0.95 | LMNA (0.34) | LMNA | |
| Hydrochloric Acid SCHEMBL15052946 | 0.95 | LMNA (0.34) | LMNA | |
| Iodide SCHEMBL15053220 | 0.95 | LMNA (0.34) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3194371-B1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY SCIENCE TECH & RES (SG) | 2020-09-02 | — | — | EP | disclosed |
| US-10570097-B2 | Antimicrobial imidazolium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-02-25 | — | — | US | disclosed |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-01-17 | — | — | US | disclosed |
| US-10160728-B2 | Antimicrobial imidazolium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-12-25 | — | — | US | disclosed |
| US-9926478-B2 | Highly durable superhydrophobic, oleophobic and anti-icing coatings and methods and compositions for their preparation | ROSS TECHNOLOGY CORPORATION (US) | 2018-03-27 | — | — | US | disclosed |
| US-9914849-B2 | Plunger and methods of producing hydrophobic surfaces | ROSS TECHNOLOGY CORPORATION (US) | 2018-03-13 | — | — | US | disclosed |
| US-20170291877-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-10-12 | — | — | US | disclosed |
| EP-3194371-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | Agency for Science, Technology and Research (SG) | 2017-07-26 | — | — | EP | disclosed |
| US-20160289810-A1 | Highly Durable Superhydrophobic, Oleophobic and Anti-Icing Coatings and Methods and Compositions for Their Preparation | ADT TECHNOLOGY LLC | 2016-10-06 | — | — | US | disclosed |
| WO-2016043660-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-03-24 | — | — | WO | disclosed |
| US-9279073-B2 | Methods of making highly durable superhydrophobic, oleophobic and anti-icing coatings | ROSS TECHNOLOGY CORPORATION (US) | 2016-03-08 | — | — | US | disclosed |
| US-20150030779-A1 | Highly Durable Superhydrophobic, Oleophobic and Anti-Icing Coatings and Methods and Compositions for Their Preparation | ADT TECHNOLOGY LLC | 2015-01-29 | — | — | US | disclosed |
| US-20130139309-A1 | Plunger and Methods of Producing Hydrophobic Surfaces | ROSS TECHNOLOGY CORPORATION (US) | 2013-06-06 | — | — | US | disclosed |
| US-20120045954-A1 | HIGHLY DURABLE SUPERHYDROPHOBIC. OLEOPHOBIC AND ANTI-ICING COATINGS AND METHODS AND COMPOSITIONS FOR THEIR PREPARATION | ROSS TECHNOLOGY CORPORATION (US) | 2012-02-23 | — | — | US | disclosed |
| WO-2009042277-A1 | METHOD OF PRINTING MARKS ON AN OPTICAL ARTICLE | GENERAL ELECTRIC COMPANY (US) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009042278-A1 | METHOD OF PRINTING MARKS ON AN OPTICAL ARTICLE | GENERAL ELECTRIC COMPANY (US) | 2009-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570097-B2 | Antimicrobial imidazolium compounds | CCNI, MACF1, ECI1 | LMNA 1163/4885 |
| US-10160728-B2 | Antimicrobial imidazolium compounds | CCNI, MACF1, ECI1 | LMNA 1163/4885 |
| US-20170291877-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | CCNI, MACF1, ECI1 | LMNA 1163/4885 |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | CCNI, MACF1, ECI1 | LMNA 1163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.